Vasospastic Angina: Clinical Trials

2 trials for Vasospastic Angina, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Recruiting 1
Phase 31Recruiting 1

Follow Vasospastic Angina: new trials by email Literature Review of Vasospastic Angina trials Research Report on Vasospastic Angina

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Impact of Vericiguat on Microvascular Function in Patients With Documented Vasospastic Angina Pectoris
Vericiguat - Vasospastic Angina
Phase 2CompletedAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)572025-02-102026-07-29
Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries
Amlodipine, Nebivolol, Placebo - Angina Pectoris, Microvascular Angina
Phase 2 / Phase 3RecruitingStanford University1502024-10-102024-11-27

Narrower conditions

Angina Pectoris, Variant (2)  ·  Angina Pectoris (1)  ·  Microvascular Angina (1)

Broader conditions

Angina, Unstable (2)  ·  Cardiovascular Diseases (2)  ·  Chest Pain (2)  ·  Heart Diseases (2)  ·  Myocardial Ischemia (2)  ·  Neurologic Manifestations (2)  ·  Pain (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Vascular Diseases (2)  ·  Angina Pectoris (1)

Interventions

Amlodipine (1)  ·  Nebivolol (1)  ·  vericiguat (1)

Sponsors

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Stanford University (1)

Countries

Netherlands (1)  ·  United States (1)

Top investigators

Jennifer Tremmel, MD (1)

Results publications

PMID 42034271, PMID 42670734